MultiClassMetabo: A Superior Classification Model Constructed Using Metabolic Markers in Multiclass Metabolomics

Abstract

Multiclass metabolomics has become a popular technique for revealing the mechanisms underlying certain physiological processes, different tumor types, or different therapeutic responses. In multiclass metabolomics, it is highly important to uncover the underlying biological information on biosamples by identifying the metabolic markers with the most associations and classifying the different sample classes. The classification problem of multiclass metabolomics is more difficult than that of the binary problem. To date, various methods exist for constructing classification models and identifying metabolic markers consisting of well-established techniques and newly emerging machine learning algorithms. However, how to construct a superior classification model using these methods remains unclear for a given multiclass metabolomic data set. Herein, MultiClassMetabo has been developed for constructing a superior classification model using metabolic markers identified in multiclass metabolomics. MultiClassMetabo can enable online services, including (a) identifying metabolic markers by marker identification methods, (b) constructing classification models by classification methods, and (c) performing a comprehensive assessment from multiple perspectives to construct a superior classification model for multiclass metabolomics. In summary, MultiClassMetabo is distinguished for its capability to construct a superior classification model using the most appropriate method through a comprehensive assessment, which makes it an important complement to other available tools in multiclass metabolomics. MultiClassMetabo can be accessed at http://idrblab.cn/ multiclassmetabo/.

Large Language Model-Based Natural Language Encoding Could Be All You Need for Drug Biomedical Association Prediction

“…By leveraging the latest insights, researchers have endeavored to unravel the multifaceted roles that drugs play in their associations with diverse biomedical entities . These efforts have sparked human knowledge accumulation in a range of fields, − such as drug design, disease treatment, and biochemical mechanism study . In this pursuit, numerous artificial intelligence (AI)-based methods have been proposed to analyze drug biomedical associations (DBAs) such as drug repurposing, drug interactions, and adverse drug reactions.…”